$50 Million

Syros Pharmaceuticals Inc.

At-the-market Offering

Syros Pharmaceuticals Inc.
Syros Pharmaceuticals is a biopharmaceutical company that discovers and develops medicines that control the expression of genes with the aim of treating cancer and other serious diseases. The Company has built a proprietary platform that identifies crucial genes that become dysregulated in diseased cells in order to create medicines that return cells to a non-diseased state. The Company's gene control platform allows them to create a pipeline of medicines to provide a benefit for currently underserved genomically defined patients